Run lookup
Supplier evidence · November 2, 2026
Some device types are exempt from premarket notification. A supplier’s “510(k)-exempt” claim still needs a product-code match, the right intended use and a check of the applicable limitations.
Missing number ≠ automatic failure. Exemption from 510(k) does not mean FDA approval, supplier endorsement or exemption from every other requirement.
Read the claim in context
Start with the device description on the quotation and label. In the FDA Product Classification database, compare the generic device type, product code, regulation and submission type. A class number or an establishment FEI alone does not settle exemption.
Match the quoted model’s purpose and operation to the device type. Ask for the product code and regulation number. A familiar name, registration or another product’s code is not the connection.
Read the submission type and the classification regulation. Save the source and retrieval date. “Class I” by itself is not enough, and some class II types can also be exempt.
Read the exemption limitations for that regulation’s part. Compare intended use and fundamental scientific technology. Keep any mismatch unresolved instead of assuming the exemption covers it.
Keep the two checks separate: an exemption concerns the device’s premarket-notification route. Establishment registration and listing concern the facility and its activities; they do not approve the device.
One published classification · not a supplier assessment
The FDA FMA record describes “depressor, tongue, non-surgical,” class 1, regulation 880.6230 and submission type “510(K) Exempt.” This is a device-type example, not verification of a brand, seller or shipment.
Section 880.6230 identifies a tongue depressor as a device intended to displace the tongue to facilitate examination of the surrounding organs and tissues. Its notification exemption is subject to the limitations in 21 CFR 880.9.
That limits section addresses, among other cases, a different intended use or a different fundamental scientific technology from a legally marketed device in the generic type. It also includes specific in vitro diagnostic limitations. Read the full applicable section; these two prompts are not an exhaustive test.
The description is consistent with the published generic purpose. Keep the actual label, model and manufacturer connection, then check the full limitations and other applicable obligations.
Next step: document the match. This guide has not cleared the specific item.
The diagnostic claim and sensing technology are not established by the tongue-depressor description. The borrowed product code does not resolve those differences.
Next step: request the applicable classification and regulatory basis; leave the exemption claim unresolved.
FDA classification consulted November 2, 2026 via a text representation. Cross-check: openFDA classification snapshot October 19, 2026; eCFR displays Title 21 current through October 29, 2026. Source dates are different from a product’s status today.
Avoid two shortcuts
Have an actual K-number instead? Use the 510(k) summary guide. Check recall scope and affected-item identifiers separately.
Make the next request specific
“Please identify the product code and classification regulation for the quoted model, provide the current label and intended use, and explain how that use and technology fit the applicable 510(k)-exemption limitations. Please identify the manufacturer and facility separately.”
Keep the supplier’s exact answer beside the official source URLs, dates and unresolved differences. Do not rewrite a broad “FDA approved” claim into an exemption claim on the supplier’s behalf.
Use the existing supplier evidence worksheet to hand off the packet, or run the establishment lookup once you have a facility name or identifier. This reading guide does not perform a model-specific regulatory determination.
Primary records
Sources consulted November 2, 2026. FDA classification and eCFR were read through text representations; these are not a real-time verification of a supplier. eCFR is continuously updated and is not the official legal edition of the CFR. This guide concerns the U.S. FDA pathway; it does not establish permission in other markets.